Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Slide Presentation of the 2007 Annual Meeting of AHRQ

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Figure 1: Reductions in benzodiazepine use after Triplicate Prescription Policy among patients living in neighborhoods with different racial compositions

Text Description is below the image.

Line graph showing the results of triplicate prescription policy for benzodiazepine among patients living in neighborhoods with different racial compositions. The races compared were black, Hispanic, white, and mixed. The survey period was Jan. 1988 through Jan. 1991. It measured the number of BZ recipients per 1000 continuous enrollees. The graph shows a large drop in Jan. 1989, and after that it remained at a much smaller level.

Source: Pearson et al, Arch Intern

Previous Slide Previous Slide         Contents         Next Slide Next Slide


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care